Outcome of ureacycle enzymopathies
J Clin Endocrinol Metab 82:727734 [DOI] [PubMed] [Google Scholar] Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE 1990 Effects of human growth hormone in men over 60 years old
I think if you are somebody who has severe obesity or has struggled with this all their life, I feel like most of those folks are probably either on a GLP-1 or on the path to it because the success level is so clear
Studies show that patients combining semaglutide with structured exercise regain 30 percent less weight than those relying on medication alone
Semaglutide, a GLP-1 receptor agonist that has shown remarkable results in clinical studies for weight loss, often outperforms other available therapies
doi: 10.3389/fmed.2025.1538194 Received 20 December 2024 Accepted 22 April 2025 Published 09 May 2025 Volume 12 - 2025 Edited by Claudia Fiorillo, University of Florence, Italy Reviewed by Sabina Galiniak, University of Rzeszw, Poland Juan Luis Santiago, Poland Universitario de Ciudad Real, Spain Hiroki Satooka, Shiga University of Medical Science, Japan Jie Zhang, Kunming University of Science and Technology, China Updates Copyright 2025 Luo, Hu, Zhou, Zhang, Wu and Sun
